Literature DB >> 24481253

Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.

Ana-Maria Bulau1, Marcel F Nold, Suzhao Li, Claudia A Nold-Petry, Michaela Fink, Ashley Mansell, Tobias Schwerd, Jaewoo Hong, Anna Rubartelli, Charles A Dinarello, Philip Bufler.   

Abstract

IL-37 is a fundamental inhibitor of innate immunity. Human IL-37 has a caspase-1 cleavage site and translocates to the nucleus upon LPS stimulation. Here, we investigated whether caspase-1 processing affects IL-37-mediated suppression of LPS-induced cytokines and the release from cells by analyzing a caspase-1 cleavage site mutant IL-37 (IL-37D20A). Nuclear translocation of IL-37D20A is significantly impaired compared with WT IL-37 in transfected cells. LPS-induced IL-6 was decreased in cells expressing WT IL-37 but not IL-37D20A. The function of IL-37 in transfected bone marrow-derived macrophages is nucleotide-binding oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome-dependent, because IL-37 transfection in apoptosis-associated speck-like protein containing a carboxyl-terminal caspase recruitment domain- and NLRP3-deficient cells does not reduce levels of IL-6 and IL-1β upon LPS stimulation. IL-37-expressing macrophages release both precursor and mature IL-37, but only the externalization of mature IL-37 was dependent on ATP. Precursor and mature IL-37 was also secreted from human dendritic cells and peripheral blood mononuclear cells. To determine whether IL-37 is active in the extracellular compartment, we pretreated IL-37 transgenic mice with IL-37-neutralizing antibodies before LPS challenge. In IL-37-expressing mice, neutralizing IL-37 antibodies reversed the suppression of LPS-induced serum IL-6. In contrast, the addition of neutralizing antibody did not reverse suppression of LPS-induced IL-6 in mouse macrophages transfected with IL-37. Although caspase-1 is required for nuclear translocation of intracellular IL-37 and for secretion of mature IL-37, the release of the IL-37 precursor is independent of caspase-1 activation. IL-37 now emerges as a dual-function cytokine with intra- and extracellular properties for suppressing innate inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481253      PMCID: PMC3932872          DOI: 10.1073/pnas.1324140111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

Authors:  Claudia Semino; Giovanna Angelini; Alessandro Poggi; Anna Rubartelli
Journal:  Blood       Date:  2005-03-31       Impact factor: 22.113

2.  IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.

Authors:  G Pan; P Risser; W Mao; D T Baldwin; A W Zhong; E Filvaroff; D Yansura; L Lewis; C Eigenbrot; W J Henzel; R Vandlen
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

3.  NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome.

Authors:  Cecilia B Levandowski; Christina M Mailloux; Tracey M Ferrara; Katherine Gowan; Songtao Ben; Ying Jin; Kimberly K McFann; Paulene J Holland; Pamela R Fain; Charles A Dinarello; Richard A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

4.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity.

Authors:  D Perregaux; C A Gabel
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

5.  Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling.

Authors:  Joseph A Duncan; Daniel T Bergstralh; Yanhong Wang; Stephen B Willingham; Zhengmao Ye; Albert G Zimmermann; Jenny Pan-Yun Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-02       Impact factor: 11.205

6.  Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

Authors:  Sanjay Kumar; Charles R Hanning; Michael R Brigham-Burke; David J Rieman; Ruth Lehr; Sanjay Khandekar; Robert B Kirkpatrick; Gilbert F Scott; John C Lee; Frank J Lynch; Wentao Gao; Andrea Gambotto; Michael T Lotze
Journal:  Cytokine       Date:  2002-04-21       Impact factor: 3.861

7.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

8.  Active caspase-1 is a regulator of unconventional protein secretion.

Authors:  Martin Keller; Andreas Rüegg; Sabine Werner; Hans-Dietmar Beer
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

9.  Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.

Authors:  Kristiina Rajamäki; Jani Lappalainen; Katariina Oörni; Elina Välimäki; Sampsa Matikainen; Petri T Kovanen; Kari K Eklund
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages.

Authors:  Wiggo J Sandberg; Marit Låg; Jørn A Holme; Bernd Friede; Maurizio Gualtieri; Marcin Kruszewski; Per E Schwarze; Tonje Skuland; Magne Refsnes
Journal:  Part Fibre Toxicol       Date:  2012-08-10       Impact factor: 9.400

View more
  83 in total

1.  Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.

Authors:  Jesper F Højen; Thomas A Rasmussen; Karen Lise D Andersen; Anni A Winckelmann; Rune R Laursen; Jesper D Gunst; Holger J Møller; Mayumi Fujita; Lars Østergaard; Ole S Søgaard; Charles A Dinarello; Martin Tolstrup
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

2.  Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer.

Authors:  Wei-qiang Wang; Dan Zhao; Yu-shan Zhou; Xiao-yu Hu; Zhi-na Sun; Gang Yu; Wan-tong Wu; Song Chen; Jiu-long Kuang; Guo-gang Xu; Zhong-chao Han; Bang-mao Wang; Jing-xian Yang; Xiao-ming Feng
Journal:  Acta Pharmacol Sin       Date:  2015-04       Impact factor: 6.150

Review 3.  Role of Anti-inflammatory Cytokines IL-35 and IL-37 in Asthma.

Authors:  Daiju Hu
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

4.  Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells.

Authors:  C Luo; Y Shu; J Luo; D Liu; D-S Huang; Y Han; C Chen; Y-C Li; J-M Zou; J Qin; Y Wang; D Li; S-S Wang; G-M Zhang; J Chen; Z-H Feng
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

5.  Interleukin-37 gene variants segregated anciently coexist during hominid evolution.

Authors:  Bin Kang; Shimeng Cheng; Jinbiao Peng; Jingjing Yan; Shuye Zhang
Journal:  Eur J Hum Genet       Date:  2015-01-28       Impact factor: 4.246

6.  Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.

Authors:  Y Li; M Zhao; C Guo; H Chu; W Li; X Chen; X Wang; Y Li; Y Jia; S Koussatidjoa; F Zhu; J Wang; X Wang; Q Wang; W Zhao; Y Shi; W Chen; L Zhang
Journal:  Oncogene       Date:  2017-11-06       Impact factor: 9.867

7.  Common genetic heterogeneity of human interleukin-37 leads to functional variance.

Authors:  Jingjing Yan; Yuling Zhang; Shimeng Cheng; Bin Kang; Jinbiao Peng; Xiaodan Zhang; Meichun Yuan; Wenqi Chu; Wen Zhang; Jiayin Shen; Shuye Zhang
Journal:  Cell Mol Immunol       Date:  2016-09-26       Impact factor: 11.530

Review 8.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22

9.  Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.

Authors:  Giulio Cavalli; Marije Koenders; Vassili Kalabokis; Jihye Kim; Aik Choon Tan; Cecilia Garlanda; Alberto Mantovani; Lorenzo Dagna; Leo A B Joosten; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2016-08-26       Impact factor: 7.580

Review 10.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.